Welcome
to the new MARCH Guidelines resource site
Dear Colleagues,
I am delighted to welcome you to the new MARCH guidelines. Some of you may remember the old "marc" guidelines, and this evolution has a new name to clearly identify the guidelines with cytotoxic handling (MARCH = Management and Awareness of the Risks of Cytotoxic Handling).
The MARCH Guidelines have been constructed from the best available evidence by an inter-disciplinary panel. They are subject to continual review and update, and I would encourage all users of the MARCH website to share new information and ideas with us so that important developments can be rapidly disseminated. We are also pleased to receive comments and feedback from users, good or bad!
Items of interest, current news and topical issues will be highlighted on the website, so I would encourage repeat visits to the site on a regular basis. Other valuable resources for practitioners will appear as the site develops.
On behalf of the MARCH Panel, I would like to thank our sponsors, Teva UK, for supporting this initiative in the safe handling of cytotoxic drugs. I would invite users of this site to reciprocate this support and visit the Teva website.
With Best Wishes,
Professor Graham Sewell, Chair, MARCH Panel